144 related articles for article (PubMed ID: 33327252)
1. Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.
An HJ; Koh HM; Lee JS; Song DH
Medicine (Baltimore); 2020 Dec; 99(50):e23277. PubMed ID: 33327252
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Koh HM; Kim DC; Kim YM; Song DH
Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
[TBL] [Abstract][Full Text] [Related]
3. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
4. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma.
de Almeida E Paula F; Bezerra SM; da Cunha IW; Munhoz GC; Abreu D; Lara PN; da Costa WH; Zéqui SC
Urol Oncol; 2019 Dec; 37(12):947-954. PubMed ID: 31473089
[TBL] [Abstract][Full Text] [Related]
7. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
10. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
11. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
12. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.
Li W; Liu M; Feng Y; Xu YF; Che JP; Wang GC; Zheng JH; Gao HJ
Int J Clin Exp Pathol; 2013; 6(6):1086-94. PubMed ID: 23696926
[TBL] [Abstract][Full Text] [Related]
15. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
[TBL] [Abstract][Full Text] [Related]
16. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
Lee C; Park JW; Suh JH; Moon KC
Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
[TBL] [Abstract][Full Text] [Related]
17. Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.
Miyata Y; Kanda S; Sakai H; Greer PA
Cancer Sci; 2013 Jun; 104(6):681-6. PubMed ID: 23445469
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarrays: one size does not fit all.
Eckel-Passow JE; Lohse CM; Sheinin Y; Crispen PL; Krco CJ; Kwon ED
Diagn Pathol; 2010 Jul; 5():48. PubMed ID: 20609235
[TBL] [Abstract][Full Text] [Related]
19. IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.
Wang Z; Xu L; Chang Y; Zhou L; Fu H; Zhang W; Yang Y; Xu J
Tumour Biol; 2016 Aug; 37(8):11127-34. PubMed ID: 26926076
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
